SCHEMBL23745425

SCHEMBL23745425

CCCC(C)(C)C1CCNC(=O)C1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 1/20 0.35
SLC2A1 P11166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21191549 0.86 PDE4A (0.34) CCR2
SCHEMBL7027655 0.77 TP53 (0.34)
SCHEMBL31149772 0.74 CES2 (0.33) CCR2
SCHEMBL24111111 0.74 TACR1 (0.32)
SCHEMBL22024008 0.73 CCR2 (0.36) CCR2
SCHEMBL23634129 0.73 CCR2 (0.36) CCR2
SCHEMBL20012662 0.73 GNAO1 (0.34)
SCHEMBL19558218 0.72 CCR2 (0.32) CCR2SLC2A1
SCHEMBL31083840 0.71 CCR2 (0.42) CCR2
SCHEMBL22430330 0.71 CCR2 (0.32) CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 CCR2 1018/4885SLC2A1 4441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.